LEAN GAIN 40 mg x 60 Capsules – Syntex Pharma

Description

Syntex Pharma LEAN GAIN 40 mg is a premium multi-compound research formulation combining SR-9009 (Stenabolic), MK-2866 (Ostarine), and Yohimbine into a single advanced investigational product. Designed for modern laboratory research, this unique blend enables scientists to explore the interaction between REV-ERBα signaling, androgen receptor biology, and adrenergic receptor pharmacology within a comprehensive experimental model.

By integrating three compounds with distinct molecular targets, LEAN GAIN provides researchers with a versatile platform for investigating circadian rhythm regulation, cellular metabolism, androgen receptor activation, protein metabolism, neuroendocrine communication, and energy homeostasis. Its complementary pharmacological profile makes it an ideal formulation for advanced studies in molecular biology, metabolic physiology, and endocrine research.

Each bottle contains 60 capsules, delivering a total of 40 mg of active ingredients per capsule, manufactured by Syntex Pharma under stringent pharmaceutical-quality standards. Every batch is carefully tested to ensure exceptional purity, formulation consistency, and dependable performance for professional laboratory investigations.

Key Features

• Premium three-compound research formulation
• 40 mg total active ingredients per capsule
• 60 capsules per bottle
• Combines SR-9009 (Stenabolic), MK-2866 (Ostarine), and Yohimbine
• Multi-target investigational formula for metabolic and endocrine research
• High-purity laboratory-grade formulation
• Extensively researched in circadian biology, androgen receptor signaling, and adrenergic receptor pharmacology
• Suitable for investigations involving mitochondrial biology, protein metabolism, cellular signaling, neuroendocrine physiology, and molecular endocrinology
• Manufactured under rigorous pharmaceutical-quality standards
• Intended exclusively for laboratory and scientific research applications

How It Works

LEAN GAIN combines three investigational compounds that target different biological systems, enabling researchers to study their complementary effects on cellular signaling and metabolic regulation.

• SR-9009 (Stenabolic) acts as a REV-ERBα (NR1D1) nuclear receptor agonist, allowing investigations into circadian rhythm regulation, mitochondrial function, lipid metabolism, and cellular energy homeostasis.
• MK-2866 (Ostarine) selectively binds to androgen receptors, providing a model for studying tissue-selective signaling, protein metabolism, gene transcription, and musculoskeletal physiology.
• Yohimbine is investigated for its activity at α2-adrenergic receptors, enabling research into adrenergic signaling, neuroendocrine communication, and receptor pharmacology.

Together, these complementary mechanisms provide researchers with a comprehensive platform for examining metabolic adaptation, endocrine communication, receptor-ligand interactions, intracellular signaling, and molecular physiology in advanced laboratory settings.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredients (Per Capsule):

• SR-9009 (Stenabolic)
• MK-2866 (Ostarine)
• Yohimbine

Total Active Ingredients: 40 mg per capsule

Packaging: 60 Capsules